CVR 42437069Hagens Alle 7Research and experimental development on natural sciences and engineering · NACE 7210Est. 20211 employees
Revenue 2024
DKK 436K
-159% vs 2023
EBITDA margin
87.5%
+125% vs 2023
Equity ratio
-228.1%
Financial strength
Net profit 2024
DKK 371K
+124% vs 2023
EBITDA — year on yearDKK millionsKey figuresAnnual report 2024
Revenue
DKK 436K
-159%
EBITDA
DKK 381K
+125%
Net profit
DKK 371K
+124%
Total assets
DKK 592K
+556%
Equity
DKK -1,4M
+22%
Employees
1
—
Company information
Legal name
G2B BioSolutions ApS
CVR number
42437069
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
3. juni 2021
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Company purpose
Selskabets formål er at drive virksomhed med handel, service, produktion og blandt andet at have en væsentlig positiv indvirkning på samfundet og miljøet som helhed.
Contact
Address
Hagens Alle 7
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.